Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-001821
Filing Date
2025-01-08
Accepted
2025-01-08 06:30:00
Documents
6
Period of Report
2025-01-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm252001-1_pre14a.htm PRE 14A 875784
2 GRAPHIC lg_cyclacel-4clr.jpg GRAPHIC 17219
3 GRAPHIC lg_secretarysoffistamp-bwlr.jpg GRAPHIC 13622
4 GRAPHIC px_cyclacel25pg01-4c.jpg GRAPHIC 320193
5 GRAPHIC px_cyclacel25pg02-4c.jpg GRAPHIC 176657
6 GRAPHIC sg_jeffreywbullock-bw.jpg GRAPHIC 10632
  Complete submission text file 0001104659-25-001821.txt   1555263
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-50626 | Film No.: 25516526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)